Novo Nordisk Foundation

EQS-News: SYNLAB delivers robust performance in FY 2023

Retrieved on: 
Wednesday, April 10, 2024
AOP, EV, COVID, Growth, Synnovis, Supervisory board, North, Environment, COVID-19 testing, FY, EPS, Cinven, COVID-19, Hospital, Sale, Acquisition, GBP, Ontario Teachers' Pension Plan, Novo Nordisk Foundation, Term loan, FX, Movement, State, Pharmaceutical industry

Synnovis, the South East London hospital outsourcing contract grew 12.2% in 2023 and contributed 0.6pts to the overall 2023 underlying organic growth.

Key Points: 
  • Synnovis, the South East London hospital outsourcing contract grew 12.2% in 2023 and contributed 0.6pts to the overall 2023 underlying organic growth.
  • FY 2023 adjusted EBITDA (AEBITDA) was €438 million (FY 2022: €753 million) while adjusted operating profit (AOP) was €194 million (FY 2022: €508 million) with margins of 16.6% (FY 2022: 23.2%) and 7.4% (FY 2022: 15.6%), respectively.
  • In FY 2023, adjusted net profit (Group share) was €44 million (FY 2022: €342 million), mainly due to lower COVID-19 testing volumes and higher net finance costs.
  • FY 2023 unlevered free cash flow (uFCF) was €74 million (FY 2022: €312 million).

Digital Realty to Host NVIDIA-Powered AI Supercomputer in Denmark

Retrieved on: 
Tuesday, April 2, 2024
Deep learning super sampling, H100, Digital Realty, Research, AI, DGX, Carbon, Novo Nordisk Foundation, Imagination, Investment fund, Export

The DGX SuperPOD also includes NVIDIA AI Enterprise software for pretrained models, optimized frameworks, and accelerated data science software libraries.

Key Points: 
  • The DGX SuperPOD also includes NVIDIA AI Enterprise software for pretrained models, optimized frameworks, and accelerated data science software libraries.
  • Chris Sharp, Chief Technology Officer at Digital Realty, commented, "Digital Realty is at the forefront of crafting the digital future, transcending mere infrastructure development to become architects of tomorrow.
  • We envision Digital Realty as more than a meeting place for AI; we aim to establish it as the premier nexus for private AI, where enterprises and data converge.
  • This collaboration between Digital Realty, the Novo Nordisk Foundation, EIFO, and NVIDIA marks a significant milestone in Denmark's AI research and innovation landscape.

Denmark to build one of the world's most powerful AI supercomputers, accelerating solutions to societal challenges

Retrieved on: 
Monday, March 18, 2024
Grace Hopper, Drug discovery, GPU, University, Biotechnology, Deep learning super sampling, Acceleration, H100, Business, Digital Realty, HPC, Research, AI, Deep learning, QPU, DKK, Graphics processing unit, Novo Nordisk Foundation, Ecosystem, Hopper, Safety, Investment fund, NVIDIA, Central processing unit, Government, Gefion, CPU, Export, Cryptocurrency

The collaboration is led on the Danish side by the Novo Nordisk Foundation and the Export and Investment Fund of Denmark (EIFO).

Key Points: 
  • The collaboration is led on the Danish side by the Novo Nordisk Foundation and the Export and Investment Fund of Denmark (EIFO).
  • "Drug discovery, disease diagnosis, and treatment, as well as complicated life science challenges, are examples of areas where extreme AI computing power can enable the positive transformation of our society.
  • The collaboration with NVIDIA and the resulting national AI innovation centre can help Denmark's brilliant researchers and innovators rise to the next level."
  • "Our government is committed to enhancing Denmark's global standing when it comes to cutting-edge technology alongside our unparalleled data resources.

Denmark to build one of the world's most powerful AI supercomputers, accelerating solutions to societal challenges

Retrieved on: 
Monday, March 18, 2024
Grace Hopper, Drug discovery, GPU, University, Biotechnology, Deep learning super sampling, Acceleration, H100, Business, Digital Realty, HPC, Research, AI, Deep learning, QPU, DKK, Graphics processing unit, Novo Nordisk Foundation, Ecosystem, Hopper, Safety, Investment fund, NVIDIA, Central processing unit, Government, Gefion, CPU, Export, Cryptocurrency

The collaboration is led on the Danish side by the Novo Nordisk Foundation and the Export and Investment Fund of Denmark (EIFO).

Key Points: 
  • The collaboration is led on the Danish side by the Novo Nordisk Foundation and the Export and Investment Fund of Denmark (EIFO).
  • "Drug discovery, disease diagnosis, and treatment, as well as complicated life science challenges, are examples of areas where extreme AI computing power can enable the positive transformation of our society.
  • The collaboration with NVIDIA and the resulting national AI innovation centre can help Denmark's brilliant researchers and innovators rise to the next level."
  • "Our government is committed to enhancing Denmark's global standing when it comes to cutting-edge technology alongside our unparalleled data resources.

Novo Nordisk Foundation: The revolution began at a local pub: now, the human genome can be read in just one hour

Retrieved on: 
Friday, March 15, 2024
Diagnosis, Genomics, Health, The Prize, Survival, Disease, Panton Arms, Science, COVID-19, University, DSM-IV codes, Human, NGS, Research, DNA, Human genome, Cancer, Life, University of Cambridge, Prize, Genome, Novo Nordisk Foundation, USD, Paper, Pharmaceutical industry

Understanding the genetic basis for what makes us all unique, including disease-related aspects, requires sequencing of not just one, but many, human genomes.

Key Points: 
  • Understanding the genetic basis for what makes us all unique, including disease-related aspects, requires sequencing of not just one, but many, human genomes.
  • In 2000, one human genome took over 10 years to sequence at a cost of more than 1 billion dollars.
  • Their new technology means that a human genome can be sequenced in just one hour and for less than USD 1,000, meaning millions are sequenced each year.
  • For their pioneering efforts, Sir David Klenerman and Sir Shankar Balasubramanian are receiving the 2024 Novo Nordisk Prize.

Novo Nordisk Foundation: The revolution began at a local pub: now, the human genome can be read in just one hour

Retrieved on: 
Friday, March 15, 2024
Diagnosis, Genomics, Health, The Prize, Survival, Disease, Panton Arms, Science, COVID-19, University, DSM-IV codes, Human, NGS, Research, DNA, Human genome, Cancer, Life, University of Cambridge, Prize, Genome, Novo Nordisk Foundation, USD, Paper, Pharmaceutical industry

Understanding the genetic basis for what makes us all unique, including disease-related aspects, requires sequencing of not just one, but many, human genomes.

Key Points: 
  • Understanding the genetic basis for what makes us all unique, including disease-related aspects, requires sequencing of not just one, but many, human genomes.
  • In 2000, one human genome took over 10 years to sequence at a cost of more than 1 billion dollars.
  • Their new technology means that a human genome can be sequenced in just one hour and for less than USD 1,000, meaning millions are sequenced each year.
  • For their pioneering efforts, Sir David Klenerman and Sir Shankar Balasubramanian are receiving the 2024 Novo Nordisk Prize.

Novo Nordisk Foundation awarded more than DKK 9.1 billion for purposes benefitting society in 2023

Retrieved on: 
Wednesday, March 6, 2024
Novo Nordisk Foundation, Research, Biotechnology, DKK, Antimalarial medication, Education, Investment, Food, Partnership, NIVI, Vaccine, University, Health, Climate change, Novo Holdings A/S, CO2, Protein, Tuberculosis, Science, Agriculture, Bill, Human

In 2023, the Foundation awarded more than DKK 9.1 billion, in philanthropic grants and investments, and supported a total of 751 new projects.

Key Points: 
  • In 2023, the Foundation awarded more than DKK 9.1 billion, in philanthropic grants and investments, and supported a total of 751 new projects.
  • One of its largest mission-driven initiatives in 2023 was the Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI), a research and vaccine development initiative launched in partnership with the University of Copenhagen.
  • The DKK 9.1 billion awarded in 2023 marks an increase in grant giving from previous years.
  • The Novo Nordisk Foundation Cellerator, a world-class facility for developing and upscaling cell therapies for testing in humans.

Novo Nordisk Foundation awarded more than DKK 9.1 billion for purposes benefitting society in 2023

Retrieved on: 
Wednesday, March 6, 2024
Novo Nordisk Foundation, Research, Biotechnology, DKK, Antimalarial medication, Education, Investment, Food, Partnership, NIVI, Vaccine, University, Health, Climate change, Novo Holdings A/S, CO2, Protein, Tuberculosis, Science, Agriculture, Bill, Human

In 2023, the Foundation awarded more than DKK 9.1 billion, in philanthropic grants and investments, and supported a total of 751 new projects.

Key Points: 
  • In 2023, the Foundation awarded more than DKK 9.1 billion, in philanthropic grants and investments, and supported a total of 751 new projects.
  • One of its largest mission-driven initiatives in 2023 was the Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI), a research and vaccine development initiative launched in partnership with the University of Copenhagen.
  • The DKK 9.1 billion awarded in 2023 marks an increase in grant giving from previous years.
  • The Novo Nordisk Foundation Cellerator, a world-class facility for developing and upscaling cell therapies for testing in humans.

Novo Nordisk Foundation: Researchers aim to advance quantum sensing to transform disease diagnosis and prevention

Retrieved on: 
Thursday, February 22, 2024
Chronic kidney disease, Hospital, Senior, Novo Nordisk Foundation, Field line, Research, Moses Austin, Investment, Partnership, Quantum, Institute of technology, Niels Bohr Institute, Malnutrition, Nature, Myenteric plexus, University, Biomarker, Disease, Pediatrics, Diagnosis, Heart, Science, DSM-IV codes, Brain, Laboratory, Motion, Diamond, University of Copenhagen

The Copenhagen Center for Biomedical Quantum Sensing will be established with a grant of DKK 150 million from the Novo Nordisk Foundation.

Key Points: 
  • The Copenhagen Center for Biomedical Quantum Sensing will be established with a grant of DKK 150 million from the Novo Nordisk Foundation.
  • "Quantum sensing is among the most mature of the quantum technologies and holds the potential to greatly improve medical diagnostics.
  • The Novo Nordisk Foundation has recently made substantial investments in quantum technologies, including a grant to the Novo Nordisk Foundation Quantum Computing Programme and funding for Quantum Foundry Copenhagen P/S.
  • The international quantum sensing research collaboration will consolidate and significantly strengthen the quantum sensing activities in Denmark, fostering international synergy and promoting translation into clinical applications.

Novo Nordisk Foundation: Researchers aim to advance quantum sensing to transform disease diagnosis and prevention

Retrieved on: 
Thursday, February 22, 2024
Chronic kidney disease, Hospital, Senior, Novo Nordisk Foundation, Field line, Research, Moses Austin, Investment, Partnership, Quantum, Institute of technology, Niels Bohr Institute, Malnutrition, Nature, Myenteric plexus, University, Biomarker, Disease, Pediatrics, Diagnosis, Heart, Science, DSM-IV codes, Brain, Laboratory, Motion, Diamond, University of Copenhagen

The Copenhagen Center for Biomedical Quantum Sensing will be established with a grant of DKK 150 million from the Novo Nordisk Foundation.

Key Points: 
  • The Copenhagen Center for Biomedical Quantum Sensing will be established with a grant of DKK 150 million from the Novo Nordisk Foundation.
  • "Quantum sensing is among the most mature of the quantum technologies and holds the potential to greatly improve medical diagnostics.
  • The Novo Nordisk Foundation has recently made substantial investments in quantum technologies, including a grant to the Novo Nordisk Foundation Quantum Computing Programme and funding for Quantum Foundry Copenhagen P/S.
  • The international quantum sensing research collaboration will consolidate and significantly strengthen the quantum sensing activities in Denmark, fostering international synergy and promoting translation into clinical applications.